Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.

Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.

Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.

"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"

Endoscope Drying Cabinet

Olympus Announces Launch of New Endoscope Drying Cabinet

Drying endoscope channels is a critical component of reprocessing. The ScopeLocker Air endoscope drying cabinet, manufactured by Capsa Healthcare and distributed by Olympus Corp., helps facilitate the drying process and is designed to meet society guidelines for endoscope drying and storage.

Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future

Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering

The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 18 months from issuance.

Industry Expert Byline

Neogap Therapeutics Selected for EIC Soft-landing Programme in Boston

The EIC Soft-landing Programme provides business development support and opportunities to connect with investors, academic institutions and life science stakeholders in Boston – a global hub for cancer research and biotechnology. Neogap’s combination of AI, bioinformatics and cell biology in developing personalised immunotherapy aligns well with the programme’s focus on deep tech companies.

Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies

ZOLL Announces Closing of Acquisition of Select Vyaire Ventilator Product Lines

With the acquisition complete, ZOLL will immediately make available to customers the bellavista®, fabian®*, LTV®, and 3100 HFOV product lines alongside ZOLL’s other respiratory care offerings. For these acquired product lines, all ventilators and associated consumables, service parts, accessories, and service program offerings will continue to be sold where currently available. Existing Vyaire contact channels will remain available for use during a transition period. Customers can also contact ZOLL at ventsales@zoll.com.

Getinge Completes the Acquisition of Paragonix Technologies

Getinge paid approximately USD 253 million in cash upon completion of the acquisition, on a cash and debt free basis. The earn-out payments are expected to be paid between 2024 and 2026 if agreed upon regulatory and financial performance milestones are achieved and may exceed USD 224 million in aggregate. The initial payout related to the acquisition has been financed through a bridge loan provided by SEB. The acquisition is expected to have a slightly negative impact on Getinge’s adjusted earnings per share in 2024. Getinge anticipates a positive contribution on adjusted earnings per share starting in 2028.

FDA Medical Device Updates

Our Experts - Byline Articles

Medical Imaging Technologies and Their Impact on Modern Healthcare

Healing Headlines, Transforming Lives: Hospitals in the News

ZEISS

ZEISS Launches AI-Driven Research Data Platform for Eye Care

“The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements,” says Euan S. Thomson, Ph.D., Head of the Digital Business Unit for ZEISS Medical Technology. “The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools.”

Marcus Neuroscience Institute

Marcus Neuroscience Institute Performs First Next-Generation Augmented Reality Spinal Surgery at Bethesda Hospital West

Marcus Neuroscience Institute, part of Baptist Health, at Bethesda Hospital West, is the first hospital in the state of Florida to perform and offer next-generation augmented reality spinal surgery with novel, advanced, high-resolution AR technology. The surgery was done by neurosurgeon Timothy O’Connor, M.D., director of minimally invasive and robotic spine surgery. Marcus Neuroscience Institute is one of the first medical centers in the world to use this next-generation augmented reality technology.

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Executives on the Move

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers and Opportunities in the Evolving Medical Field

Nurses Corner: A Dedicated Space for Professional Insights and Resources

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.